CRG Joins Existing Investors In New Financing Deal In Support Of Commercialization Plans Redmond, Washington. – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that it has secured...
Industry veteran offers 30 years of banking and corporate finance leadership experience Redmond, Washington – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that industry veteran...
Ambulatory Payment Classification Assignment Also Included In The Federal Register REDMOND, Washington – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), today announced the Federal Register has...
Health Economic Data for TIF Procedure Also Highlighted REDMOND, Washington – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), today announced updated one-year clinical data from the RESPECT...
